From: The association of glycemic level and prevalence of tuberculosis: a meta-analysis
Study | Type of study | Populations | TB | Non-TB | P | ||||
---|---|---|---|---|---|---|---|---|---|
Exposure | n | Mean ± SD/Median [IQR] | Exposure | n | Mean ± SD/Median [IQR] | ||||
Leal 2019 | Case-control study | DM (n = 135) | FPG (mg/dL) | 31 | Mean ± SD: 193.17 ± 1.83 | FPG (mg/dL) | 90 | Mean ± SD: 145.04 ± 36.92 | 0.001 |
Khalil 2016 | Case-control study | DM (n = 80) | FPG (mg/dL) | 80 | Mean ± SD: 214.28 ± 67.43 | FPG (mg/dL) | 80 | Mean ± SD: 153.53 ± 41.03 | < 0.01 |
Kumpatla 2013 | A cross–sectional study | DM (n = 6967) | FPG (mg/dL) | 47 | Mean ± SD: 189.4 ± 75.1 | FPG (mg/dL) | 6920 | Mean ± SD: 170.4 ± 69.7 | 0.17 |
Sanchez-Jimenez 2018 | A cross–sectional study | DM (n = 50) | FPG (mg/dL) | 25 | Mean ± SD: 107.3 ± 60.1 | FPG (mg/dL) | 25 | Mean ± SD: 186.6 ± 91.4 | <  0.0001 |
Berkowitz 2018 | A cross–sectional study | DM (n = 440) | FPG (mmol/L) | 13 | Median [IQR]: 8.2 [6.3–10.4] | FPG (mmol/L) | 421 | Median [IQR]: 8.2 [6.1–11.7] | Not shown |
Martinez-Aguilar 2015 | A cross–sectional study | DM (n = 600) | FPG (mg/dL) | 308 | Median [IQR]: 164 [126.2–237.5] | FPG (mg/dL) | 292 | Median [IQR]: 169 [126.5–234.5] | 0.81 |
Marupuru 2017 | Case–control study | DM (n = 451) | FPG (mg/dL) | 152 | Median [IQR]: 178 [124–243] | FPG (mg/dL) | 299 | Median [IQR]: 163 [125–234] | Not shown |